See every side of every news story
Published loading...Updated

VentureMed Names Jordan Kepper as CMO and Announces Study Results for Flex VP System - Endovascular Today

Summary by Endovascular Today
March 14, 2025—VentureMed Group, Inc., a medical device company focused on arteriovenous access and peripheral arterial disease, recently announced the appointment of Jordan Knepper, MD, as Chief Medical Officer. According to VentureMed, Dr. Knepper is a vascular surgeon and Associate Professor of Surgery at Michigan State University in East Lansing, Michigan. Dr. Knepper succeeds John Pigott, MD, who remains as Founder & Critical Advisor. The c…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endovascular Today broke the news in on Friday, March 14, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.